Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2903 | 2040 | 40.1 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1147 | 9087 | CELL TRANSFORMATION ASSAY//ONCOGENIC RAS P21//BHAS 42 CELLS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ONCOGENIC RAS P21 | Author keyword | 26 | 100% | 1% | 11 |
2 | EFFECTOR DOMAINS | Author keyword | 11 | 78% | 0% | 7 |
3 | N RAS | Author keyword | 6 | 21% | 1% | 24 |
4 | RAS P21 PROTEIN | Author keyword | 5 | 54% | 0% | 7 |
5 | N RAS ONCOGENE | Author keyword | 4 | 46% | 0% | 6 |
6 | RAS ONCOGENE | Author keyword | 3 | 12% | 1% | 23 |
7 | PATHOL FORENS VET | Address | 3 | 60% | 0% | 3 |
8 | RAS P 21 | Author keyword | 2 | 67% | 0% | 2 |
9 | SOS PROTEIN | Author keyword | 2 | 67% | 0% | 2 |
10 | UNIVERSAL HETERODUPLEX GENERATOR | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCOGENIC RAS P21 | 26 | 100% | 1% | 11 | Search ONCOGENIC+RAS+P21 | Search ONCOGENIC+RAS+P21 |
2 | EFFECTOR DOMAINS | 11 | 78% | 0% | 7 | Search EFFECTOR+DOMAINS | Search EFFECTOR+DOMAINS |
3 | N RAS | 6 | 21% | 1% | 24 | Search N+RAS | Search N+RAS |
4 | RAS P21 PROTEIN | 5 | 54% | 0% | 7 | Search RAS+P21+PROTEIN | Search RAS+P21+PROTEIN |
5 | N RAS ONCOGENE | 4 | 46% | 0% | 6 | Search N+RAS+ONCOGENE | Search N+RAS+ONCOGENE |
6 | RAS ONCOGENE | 3 | 12% | 1% | 23 | Search RAS+ONCOGENE | Search RAS+ONCOGENE |
7 | RAS P 21 | 2 | 67% | 0% | 2 | Search RAS+P+21 | Search RAS+P+21 |
8 | SOS PROTEIN | 2 | 67% | 0% | 2 | Search SOS+PROTEIN | Search SOS+PROTEIN |
9 | UNIVERSAL HETERODUPLEX GENERATOR | 2 | 67% | 0% | 2 | Search UNIVERSAL+HETERODUPLEX+GENERATOR | Search UNIVERSAL+HETERODUPLEX+GENERATOR |
10 | RAS ONCOPROTEIN | 2 | 50% | 0% | 3 | Search RAS+ONCOPROTEIN | Search RAS+ONCOPROTEIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENCODED P21 PROTEIN | 13 | 80% | 0% | 8 |
2 | P21 GTPASE | 12 | 52% | 1% | 16 |
3 | RAS P21 GTPASE | 11 | 35% | 1% | 25 |
4 | MURINE SARCOMA VIRUS | 11 | 19% | 3% | 51 |
5 | ONCOGENIC RAS P21 | 9 | 52% | 1% | 12 |
6 | NUCLEOTIDE EXCHANGE REACTION | 7 | 64% | 0% | 7 |
7 | WILD TYPE RAS P21 | 6 | 80% | 0% | 4 |
8 | P21 PROTEIN | 6 | 38% | 1% | 12 |
9 | RAF P74 PROTEIN | 4 | 75% | 0% | 3 |
10 | TRANSFORMING GENES | 4 | 18% | 1% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
RAS GENES | 1987 | 4231 | 265 | 60% |
FUNCTION AND REGULATION OF RAS | 1993 | 904 | 299 | 43% |
RAS GTPASE ACTIVATING PROTEIN - SIGNAL TRANSMITTER AND SIGNAL TERMINATOR | 1989 | 539 | 10 | 50% |
MUTATIONS OF RAS GENES IN HUMAN TUMORS (REVIEW) | 1995 | 173 | 117 | 37% |
FUNCTION OF RAS AS A MOLECULAR SWITCH IN SIGNAL TRANSDUCTION | 1992 | 411 | 74 | 30% |
THE RAS SIGNAL-TRANSDUCTION PATHWAY | 1994 | 254 | 182 | 28% |
THE EFFECTOR INTERACTIONS OF P21(RAS) | 1993 | 199 | 28 | 54% |
Anti-cancer Peptides from Ras-P21 and P53 Proteins | 2011 | 1 | 63 | 48% |
REGULATORS AND EFFECTORS OF RAS PROTEINS | 1991 | 281 | 222 | 40% |
RAS ONCOGENES - THEIR ROLE IN NEOPLASIA | 1990 | 248 | 34 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOL FORENS VET | 3 | 60% | 0.1% | 3 |
2 | MICROBIOL HUMAN GENET | 2 | 50% | 0.1% | 3 |
3 | PATHOL MED 113 | 1 | 31% | 0.2% | 4 |
4 | MOLEC DEV BIOL 600 UNIV AVE | 1 | 40% | 0.1% | 2 |
5 | BIOL 48 VAS CONSTANTINOU AVE | 1 | 33% | 0.1% | 2 |
6 | BIOACT MOLEC SHINJUKU KU | 1 | 50% | 0.0% | 1 |
7 | LAIKON HOSP MED | 1 | 50% | 0.0% | 1 |
8 | LEUKAEMIA FUND DIFFERENTIAT GRP | 1 | 50% | 0.0% | 1 |
9 | MOL TECHNOL DRUG DESIGN SYNTH | 1 | 50% | 0.0% | 1 |
10 | 48 VAS CONSTANTINOU AVE | 1 | 22% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000253441 | HA RAS//MIHALY PEKAR MED LIFE SCI LIB//HISTOL PATHOL ANAT SECT |
2 | 0.0000231134 | L MYC//H RAS MINISATELLITE//L MYC POLYMORPHISM |
3 | 0.0000140395 | FARNESYLTHIOSALICYLIC ACID//SALIRASIB//ABT STRUKTURELLE BIOL |
4 | 0.0000138825 | MSSP//C MYC PROTEIN//ONCOGENE RESEARCH |
5 | 0.0000123031 | CDC25MM//RAS GRF1//BCY1 |
6 | 0.0000088069 | IMMORTALIZATION OF HUMAN CELLS//IMMORTALIZED HUMAN CELLS//MOL ENVIRONM HLTH |
7 | 0.0000086716 | V ERB B//V ERBB//ACUTE RETROVIRUS |
8 | 0.0000085678 | CELL BIOL CANC GENET//MICROCELL HYBRIDIZATION//MICROCELL FUSION |
9 | 0.0000076964 | BIOMARKERS BRANCH//CLONOGEN//COLORADO PARTY |
10 | 0.0000072417 | RAP1//EPAC//EPAC1 |